References
Grobmyer SR, Pederson HJ, Valente SA, Al-Hilli Z, Radford D, Djohan R, et al. Evolving indications and long-term oncological outcomes of risk-reducing bilateral nipple-sparing mastectomy. BJS Open. 2019;3(2):169–73.
Fischer JP, Wes AM, Tuggle CT III, Serletti JM, Wu LC. Risk analysis of early implant loss after immediate breast reconstruction: a review of 14,585 patients. J Am Coll Surg. 2013;217(6):983–90.
McCullough MC, Chu CK, Duggal CS, Losken A, Carlson GW. Antibiotic prophylaxis and resistance in surgical site infection after immediate tissue expander reconstruction of the breast. Ann Plast Surg. 2016;77(5):501–5.
ElSherif A, Cocco D, Armanyous S, Cummins A, Shaffer K, Duraes EFR, et al. Nipple sparing mastectomy: are we providing proper prophylactic antibiotic coverage? Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-10449-5.
Reish RG, Damjanovic B, Austen WG Jr, Winograd J, Liao EC, Cetrulo CL, et al. Infection following implant-based reconstruction in 1952 consecutive breast reconstructions: salvage rates and predictors of success. Plast Reconstr Surg. 2013;131(6):1223–30.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
ElSherif, A., Valente, S.A. ASO Author Reflections: Is Cefazolin Enough with Implant Reconstruction? Does Retaining the Nipple Make a Difference?. Ann Surg Oncol 29 (Suppl 3), 554–555 (2022). https://doi.org/10.1245/s10434-021-10607-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-021-10607-9